NASDAQ
Revance Therapeutics, Inc. (RVNC) has a current ratio of 3.80x as of Monday, May 25, 2026. This represents a 34.60% decrease compared to its 12-month average of 5.81x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.